A longitudinal model for disease progression was developed and applied to multiple sclerosis

J Clin Epidemiol. 2015 Nov;68(11):1355-65. doi: 10.1016/j.jclinepi.2015.05.003. Epub 2015 May 14.

Abstract

Objectives: To develop a model of disease progression using multiple sclerosis (MS) as an exemplar.

Study design and settings: Two observational cohorts, the University of Wales MS (UoWMS), UK (1976), and British Columbia MS (BCMS) database, Canada (1980), with longitudinal disability data [the Expanded Disability Status Scale (EDSS)] were used; individuals potentially eligible for MS disease-modifying drugs treatments, but who were unexposed, were selected. Multilevel modeling was used to estimate the EDSS trajectory over time in one data set and validated in the other; challenges addressed included the choice and function of time axis, complex observation-level variation, adjustments for MS relapses, and autocorrelation.

Results: The best-fitting model for the UoWMS cohort (404 individuals, and 2,290 EDSS observations) included a nonlinear function of time since onset. Measurement error decreased over time and ad hoc methods reduced autocorrelation and the effect of relapse. Replication within the BCMS cohort (978 individuals and 7,335 EDSS observations) led to a model with similar time (years) coefficients, time [0.22 (95% confidence interval {CI}: 0.19, 0.26), 0.16 (95% CI: 0.10, 0.22)] and log time [-0.13 (95% CI: -0.39, 0.14), -0.15 (95% CI: -0.70, 0.40)] for BCMS and UoWMS, respectively.

Conclusion: It is possible to develop robust models of disability progression for chronic disease. However, explicit validation is important given the complex methodological challenges faced.

Keywords: Fractional polynomials; Multilevel model; Multiple sclerosis; Observational cohorts; Prognosis; Repeated measures model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Disease Progression*
  • Female
  • Humans
  • Male
  • Models, Statistical*
  • Multiple Sclerosis* / epidemiology